Clinical Trial Update: Renal Artery Denervation in Chronic Heart Failure Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating renal artery denervation for chronic systolic heart failure; sponsor Imperial College London; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction
• Systolic Heart Failure

Snippet

Sponsor: Imperial College London | Conditions: Chronic Systolic Heart Failure | Phase 3 | Status: UNKNOWN